In line with earlier studies of the general population, the findings should encourage a thoughtful approach to calcium, ...

The absolute rate is still below 0.5%, in line with prior ablation studies, but the issue warrants monitoring, a researcher ...

This month: dental costs and increased CVD risk, targeting fear of movement, workplace wellness programs, and more.

NEW ORLEANS, LA—Adding the factor XIa inhibitor asundexian (Bayer) to antiplatelet therapy tops antiplatelet therapy alone ...

Yet the evidence should not be overinterpreted, as conventional pacing maintains an important role, says Elena Arbelo.

At 30 days, bleeding and pacemaker rates were lower than in TRISCEND II, but long-term outcomes are eagerly awaited.

The addition of stenting to usual care reduced symptoms and improved quality of life for patients with the condition after ...

Known for his skills as a clinician and educator, Montorfano contributed much to the interventional cardiology community.

Patients at high risk for pulmonary complications had similar support needs at 90 days with HFNOT or standard oxygen.

Risk-factor control was poorer in female patients, who had a lower likelihood of reaching LDL and physical activity targets.

Among patients with a single CTO lesion, the study found an improvement in health status compared with medical therapy.

The IMPACTS-BP trial showed that SPRINT-like reductions in systolic BP are possible even in tough real-world scenarios.